Daniel Hamstra, MD, PhD

Daniel Hamstra, MD, PhD,  physician,&nbsp;Texas Center for Proton Therapy, Texas Oncology, discusses the benefits of shorter radiotherapy treatment sessions for patients with prostate cancer. Hamstra says on average, patients come in to receive radiotherapy for about two months, five days per week, on average. With shorter, equally efficacious doses of radiotherapy, these patients can continue on with their day-to-day lives less impeded by their treatment.

Videos

&#8203;Daniel Hamstra, MD, PhD, radiation oncologist, Texas Center for Proton Therapy, Texas Oncology, discusses the benefits of shorter radiotherapy treatment sessions for patients with prostate cancer.

Dr. Daniel Hamstra on the Benefits of Shorter Radiation Therapy Sessions for Prostate Cancer

Daniel Hamstra, MD, PhD, radiation oncologist, Texas Center for Proton Therapy, Texas Oncology, discusses radiotherapy in different doses as a treatment for prostate cancer. Hamstra says that shorter regimens of radiotherapy for men whose prostates remained in tact post-surgery proved to be noninferior when compared to longer regimens. He adds that these shorter regimens are more convenient for patients, as well as more cost effective.

Hamstra says the study titled RTOG 0415, conducted with roughly 1000 patients in the United States, compared an 8 week regimen of radiotherapy to a regimen of 5.5 weeks and found that the outcomes were "virtually identical" for recurrence and long term side effects. Hamstra adds that there was a very small increase in gastrointestinal side effects. The CHIP trial, conducted in Great Britain with over 3000 patients, resulted with similar data.

Hamstra says that shorter regimens of radiotherapy for men whose prostates remained in tact post-surgery proved to be noninferior when compared to longer regimens. He adds that these shorter regimens are more convenient for patients, as well as more cost effective.

Daniel Hamstra, MD, PhD | Authors

Articles

Dr. Daniel Hamstra on the Benefits of Shorter Radiation Therapy Sessions for Prostate Cancer

Dr. Daniel Hamstra on the Noninferiority of Shorter Radiotherapy Regimens in Prostate Cancer